Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1119 of 6351
-
Supercharged immune cells take on blood cancers in new trial
Disease control Recruiting nowSubjects on this study have a type of lymph gland cancer called Non-Hodgkin Lymphoma, acute lymphocytic leukemia, or chronic Lymphocytic Leukemia (these diseases will be referred to as "lymphoma" or "leukemia"). The lymphoma or leukemia has come back or has not gone away after tr…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a faster ovarian suppression drug improve breast cancer treatment?
Disease control CompletedThe purpose of the this study is to investigate the anti-tumor activity and tolerability of the study medications Degarelix and Triptorelin in premenopausal women receiving preoperative treatment with Letrozole.
Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Artificial pancreas implant shows promise for diabetes control
Disease control OngoingThe primary objective of this clinical investigation is to investigate the safety of implantation of the human islet containing device Beta-Air in type 1 diabetic subjects. The secondary objective of this clinical investigation is to investigate if the transplantation of macro-e…
Phase 1/2 • Sponsor: Uppsala University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
AI reads your Heart's electrical signals to predict failure years in advance
Knowledge-focused CompletedThis study aims to develop and validate a deep learning-based electrocardiogram (ECG) model for predicting the future risk of heart failure with reduced ejection fraction (HFrEF). The model is trained using raw 12-lead ECG data and generates individualized, time-resolved risk est…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New hope for young breast cancer patients: freezing eggs before chemo
Disease control OngoingThe rates of patients with spontaneous pregnancies reported after breast cancer is between 3 and 7%, particularly because of these treatments. Therefore, it is essential to anticipate this problem by proposing the use of fertility preservation techniques for these young patients…
Phase 2 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
PET scans may predict breast cancer drug response before surgery
Knowledge-focused OngoingThis research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which patients are most likely to respond to the combination of trastuzumab and pertuzumab when given prior to surgery.
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New pill shows promise in taming Hard-to-Treat blood cancers
Disease control OngoingThis study is evaluating the safety and efficacy of a new BTK inhibitor, acalabrutinib, for the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Phase 1/2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
High-dose radiation aims to control tough prostate cancer
Disease control OngoingThis clinical trial studies stereotactic body radiation therapy in treating patients with high-risk prostate cancer that has not spread to nearby lymph nodes or to other parts of the body. Stereotactic body radiation therapy is a specialized radiation therapy that delivers a sing…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Two-Drug combo shows promise against tough skin cancer
Disease control CompletedThis randomized phase II trial studies how well ipilimumab with or without bevacizumab works in treating patients with stage III-IV melanoma that cannot be removed by surgery. Immunotherapy with monoclonal antibodies, such as ipilimumab and bevacizumab, may help the body's immune…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Targeted drug shows promise for rare blood cancer in completed trial
Disease control CompletedThe purpose of this study is to assess the antitumor efficacy of single-agent brentuximab vedotin 1.8 mg/kg administered intravenously (IV) every 3 weeks, as measured by the overall objective response rate (ORR) in patients with r/r sALCL following at least 1 multiagent chemother…
Phase 4 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 26, 2026 19:04 UTC
-
Can less radiation after throat surgery be just as effective?
Disease control OngoingThis randomized phase II trial studies how well transoral surgery followed by low-dose or standard-dose radiation therapy works in treating patients with human papilloma virus (HPV) positive stage III-IVA oropharyngeal cancer. Radiation therapy uses high-energy x-rays to kill tum…
Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Experimental combo shows promise for Tough-to-Treat leukemia
Disease control CompletedThis phase II trial studies how well anti-cluster of differentiation (CD)19 monoclonal antibody MOR00208 and lenalidomide work in treating patients with relapsed, refractory, or previously untreated chronic lymphocytic leukemia, small lymphocytic lymphoma, or prolymphocytic leuke…
Phase 2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Major CLL study tests which drug combo works best for seniors
Disease control OngoingThis randomized phase III trial studies rituximab with bendamustine hydrochloride or ibrutinib to see how well they work compared to ibrutinib alone in treating older patients with previously untreated chronic lymphocytic leukemia. Rituximab is a monoclonal antibody that may inte…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Blood vessel cells in a simple blood test may predict ovarian cancer therapy success
Knowledge-focused CompletedAnti-angiogenic agents, such as Bevacizumab, have demonstrated survival benefits in ovarian cancer, particularly in patients at high risk of disease progression. However, these therapies are costly, associated with potential side effects, and may negatively impact quality of life…
Sponsor: Centro di Riferimento Oncologico - Aviano • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Pancreas cancer screening trial enrolls 9,000 High-Risk individuals
Diagnosis Recruiting nowJohns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.
Phase 3 • Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Proton vs. photon: which radiation beats lung cancer best?
Disease control OngoingThis randomized phase III trial studies proton chemoradiotherapy to see how well it works compared to photon chemoradiotherapy in treating patients with stage II-IIIB non-small cell lung cancer that cannot be removed by surgery. Specialized radiation therapy that delivers a high …
Phase 3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Smaller liver grafts could revolutionize transplant safety
Disease control By invitation onlyThe objective of this observational study is to compare the safety profile of auxiliary liver transplantation using small-for-size grafts with that of conventional liver transplantation and to evaluate the efficacy of this technique. The primary research question it seeks to inve…
Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can targeted temperature control boost brain recovery after cardiac arrest?
Knowledge-focused By invitation onlyCardiac arrest is one of the leading life-threatening emergencies, with approximately 540,000 cases occurring annually in China. Among patients who experience cardiac arrest, active cardiopulmonary resuscitation can achieve return of spontaneous circulation in 40% of cases; howev…
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can an antihistamine help heal MS?
Disease control CompletedThe main purpose of this study is to assess clemastine as a remyelinating agent in patients with relapsing forms of multiple sclerosis. The study will also evaluate the tolerability of clemastine, originally approved as first-generation antihistamine, in patients with multiple sc…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 26, 2026 18:30 UTC
-
Could MRI spot prostate cancer earlier in High-Risk men?
Diagnosis OngoingMen with a BRCA1 or BRCA2 mutation are at increased risk for early onset, aggressive prostate cancer compared to men in the general population. Standard of care screening for men with a BRCA mutation includes PSA testing and digital rectal examination (DRE), the same as with men…
Sponsor: Toronto Sunnybrook Regional Cancer Centre • Aim: Diagnosis
Last updated Jun 26, 2026 15:05 UTC